SIRVE
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90390332
- Registration number
- 7706575
- Mark type
- Stylized text
- Filed
- 17 Dec 2020
- Published for opposition
- 04 May 2021
- Registered
- 25 Feb 2025
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Biological and biochemical preparations for use in industry and science
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, musculoskeletal, cardiovascular, hepatological, and hormonal diseases and disorders
Owner
- Kriya Therapeutics, Inc., Morrisville, NC, US
- Kriya Therapeutics, Inc., Morrisville, NC, US
- Kriya Therapeutics, Inc., Redwood City, CA, US
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Nov 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 21 Nov 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 06 Nov 2024 — ASSIGNED TO EXAMINER
- 21 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Aug 2024 — NON-FINAL ACTION E-MAILED
- 21 Aug 2024 — SU - NON-FINAL ACTION - WRITTEN
- 02 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Jul 2024 — USE AMENDMENT FILED
- 01 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 23 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED